Pain Relief Portfolio
13 July 2015
Notice of Pain Relief Portfolio Study Results
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, intends to announce the headline results from the clinical study of its portfolio of three topical pain relief products on Tuesday 14 July 2015 at 7.00am
A presentation for analysts will be held at 10.00am on 14 July 2015 at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN, to discuss the results of the study.
For further information please contact:
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Sophie Cowles /
Tel: +44 (0) 20 7466 5000
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.